Dr. Markus F. Renschler MD
Hematologist-Oncologist | Hematology & Oncology
300 Pasteur Dr Stanford CA, 94305About
Dr. Markus Renschler is a hematologist oncologist practicing in Stanford, CA. Dr. Renschler specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
- Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
- Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.
- Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
- Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
- The emerging role of reactive oxygen species in cancer therapy.
- Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme.
- Avoiding needle-stick injuries in the emergency department.
- Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
- Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy.
- Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.
- Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
- Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors.
- Avoiding exposure to HIV by needle stick.
Dr. Markus F. Renschler MD's Practice location
Dr. Markus F. Renschler MD's reviews
Write ReviewRecommended Articles
- Daughter's Donation Gives Mom with Lymphoma a Fighting Chance
Chyanne Ojageer, a 14-year-old teenager from Kissimmee, Florida, became one of the youngest bone marrow donors in the state when she donated her own bone marrow to help save her mother’s life.Neisha Ojageer, never in her wildest dreams thought that her daughter would be the person to save her...
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- Nurse Donates Breast Milk for Lymphoma Patient's Baby
Ashley Chestnut, a mother of two children from La Vista, Nebraska, was breastfeeding her 5-month-year-old son Easton when she began to experience a sharp and sudden pain in her shoulder and chest. “All of a sudden a sharp pain in my shoulder and chest, it was like hitting a freight train. It was...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission
4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
Nearby Providers
- Thorsten Graef995 East Arques Avenue Sunnyvale California 94085
- Dr. Ostap G Melnyk MD13847 E 14th St San Leandro CA 94578
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Peter Samuel Galatin M.D., PH.D.2585 Samaritan Dr San Jose CA 95124
- Dr. Saul Rosenberg M.D.269 Campus Dr Stanford CA 94305
- Dr. Alexander Dimitrios Colevas MD875 Blake Wilbur Drive Stanford CA 94305